Puthenkalam Narayanan Kutty Menon Ganga Mohan

Puthenkalam Narayanan Kutty Menon Ganga Mohan

Director Director DIN 05204021
DIN 05204021 First appointment Mar 2012 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Mar 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Puthenkalam Narayanan Kutty Menon Ganga Mohan

Data last updated:

Puthenkalam Narayanan Kutty Menon Ganga Mohan was a Director at Adventmed Biogenerics Private Limited (2012–2016). The company operates in Professional Services.

DIN 05204021
Primary Designation Director
Industry Professional Services
First Appointment 13 Mar 2012

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Mar 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Adventmed Biogenerics Private Limited
Premium access

Shareholding and investment profile for Puthenkalam Narayanan Kutty Menon Ganga Mohan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Puthenkalam Narayanan Kutty Menon Ganga Mohan

Puthenkalam Narayanan Kutty Menon Ganga Mohan was first appointed on 13 Mar 2012 as Director at Adventmed Biogenerics Private Limited.

Puthenkalam Narayanan Kutty Menon Ganga Mohan held 1 earlier board appointment: Adventmed Biogenerics Private Limited (Director, 13 Mar 2012 to 14 Apr 2016).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available